SWK (NASDAQ:SWKH) Lowered to "Hold" Rating by Wall Street Zen

SWK (NASDAQ:SWKH - Get Free Report) was downgraded by investment analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a research note issued on Thursday.

Separately, Maxim Group reduced their price objective on SWK from $21.00 to $18.00 and set a "buy" rating for the company in a research report on Monday, May 19th.

SWK Price Performance

SWK stock traded up $0.06 during trading hours on Thursday, hitting $14.20. The stock had a trading volume of 12,610 shares, compared to its average volume of 13,322. The company has a debt-to-equity ratio of 0.11, a current ratio of 5.06 and a quick ratio of 5.06. The stock has a market capitalization of $174.23 million, a price-to-earnings ratio of 15.27 and a beta of 0.21. SWK has a 1-year low of $13.17 and a 1-year high of $20.49. The stock's fifty day moving average is $15.89 and its two-hundred day moving average is $16.18.

SWK (NASDAQ:SWKH - Get Free Report) last released its quarterly earnings data on Thursday, May 15th. The company reported $0.66 EPS for the quarter, topping analysts' consensus estimates of $0.29 by $0.37. The company had revenue of $11.83 million for the quarter. SWK had a return on equity of 5.07% and a net margin of 26.51%.

Hedge Funds Weigh In On SWK

Several large investors have recently made changes to their positions in the business. Rangeley Capital LLC bought a new stake in shares of SWK in the 4th quarter valued at approximately $692,000. Dynamic Advisor Solutions LLC acquired a new position in shares of SWK in the 1st quarter valued at $378,000. M3F Inc. raised its stake in SWK by 2.5% during the 4th quarter. M3F Inc. now owns 800,151 shares of the company's stock worth $12,690,000 after buying an additional 19,279 shares during the period. Millennium Management LLC acquired a new stake in SWK during the 4th quarter worth $235,000. Finally, JPMorgan Chase & Co. raised its stake in SWK by 102.2% during the 4th quarter. JPMorgan Chase & Co. now owns 12,350 shares of the company's stock worth $196,000 after buying an additional 6,242 shares during the period. Institutional investors and hedge funds own 99.27% of the company's stock.

SWK Company Profile

SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors.